State of the art therapy in multiple myeloma and future perspectives
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference76 articles.
1. Medical Research Council Adult Leukaemia Working Party. High-dose chemotherapy with haematopoietic stem-cell rescue for multiple myeloma;Child;N Engl J Med,2003
2. Comparison of high-dose melphalan with a more intensive regimen of thiotepa, busulfan, and cyclophosphamide for patients with multiple myeloma;Anagnostopoulos;Cancer,2004
3. InterGroupe Francophone du Myelome. Single versus double autologous stem-cell transplantation for multiple myeloma;Attal;N Engl J Med,2003
4. Melphalan plus total body irradiation (MEL-TBI) or cyclophosphamide (MEL-CY) as a conditioning regimen with second autotransplant in responding patients with myeloma is inferior compared to historical controls receiving tandem transplants with melphalan alone
5. International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 2003; 121: 749–757.
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Usability of German hospital administrative claims data for healthcare research: General assessment and use case of multiple myeloma in Munich university hospital in 2015–2017;PLOS ONE;2022-07-28
2. Targeting cancer stem cell pathways for cancer therapy;Signal Transduction and Targeted Therapy;2020-02-07
3. Comparative binding studies of curcumin and tangeretin on up-stream elements of NF-kB cascade: a combined molecular docking approach;Network Modeling Analysis in Health Informatics and Bioinformatics;2019-06-19
4. Outcome of patients with multiple myeloma and renal failure on novel regimens;Saudi Journal of Kidney Diseases and Transplantation;2016
5. Aberrant Immunoglobulin Variations as Indicators of Eventual Clonal Changes in Symptomatic Multiple Myeloma Patients' Course;Current Cancer Therapy Reviews;2014-11-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3